Cancer vaccine approved for clinical trials in Lubbock

Set Text Size SmallSet Text Size MediumSet Text Size LargeSet Text Size X-Large
Updated: 3/19/2014 11:02 am
A group of doctors who work at the Texas Tech Health Sciences Center have established Kiromic, LLC.

"We're very excited about what the future holds," CEO Dr. Scott Dahlbeck said.

As the company's slogan reads, they feel they have the "key to cancer's cure."

"And the reason we feel that way is we discovered a new method to harness the patient's own immune system to fight cancer," Dr. Dahlbeck explained.

He said a major selling point for the treatment is that it is unique from chemotherapy, radiation and surgery.

"This treatment actually targets the tumor and it does so in a way that should be safer and more natural to the patient because it uses their own immune system."

So here is how the process works...

"The protocols we have with the FDA, they're called dendritic vaccines. And what (we) do is we basically take the patients own white blood cells. We train those cells on how to attack the tumor. We inject them back into the patient. They fight the cancer and stimulate the patient's own immune system - to sort of wake up and be able to attack and fight the tumor."   

He said the vaccine's development is thanks in large part to the company's chief science officer, Dr. Maurizio Chiriva, who has been working in immunotherapy for 15 years. 

"We've found the proteins that are produced by the cells. We've isolated those, identified them, and now when can use them to diagnose the tumor as well as treat the tumor," Dahlbeck said.

The team was granted FDA approval more than a  month ago and is looking to begin clinical trials by May 1st.

"Number one, we want to make sure it's safe. Number two, we want to make sure that it works and that it has potential to cure. Then we will launch into phase three. And it will be compared to whatever is standard in care for that particular tumor type and we'll see which one's better."

Dahlbeck said about 20 local cancer patients will be involved in the first phase which should take less than a year.

Watch the attached video for more on this story.

Click here for Kiromic's website.
0 Comment(s)
Comments: Show | Hide

Here are the most recent story comments.View All

No comments yet!
Lubbock Weather

Wind: SSE 9 mph
Feels Like: 61°
High: 77°
Low: 47°
Latest Product Recalls
Only small number of Jeeps fixed 2 years after recall began
Nearly two years after agreeing to recall 1.56 million older Jeeps that could catch fire in rear-end crashes, Fiat Chrysler U.S. has repaired only 4 percent of the Grand Cherokees and 27 percent of the Libertys covered by the recall.
GM recalls Chevy Malibus to fix sunroof control issue
General Motors is recalling nearly 92,000 Chevrolet Malibu midsize sedans to fix a problem with the power sunroof controls.
Mercedes recalls 30,000 cars to fix rear tail lamp problem
Mercedes-Benz is recalling just over 30,000 CLS-Class cars in the U.S. because the LED tail lamps may not light properly on the sides.
GM recalling 51,640 SUVs for defective fuel gauges
General Motors is recalling 51,640 SUVs because the fuel gauges may show inaccurate readings. The recall involves the Buick Enclave, Chevrolet Traverse and GMC Acadia from the 2014 model year.
GM recalls more than 56,000 Saturns for shifting defect
General Motors is recalling about 56,214 Saturn Aura midsize cars in the U.S. because the automatic transmission shifters can fail. The recall affects certain cars from the 2007 and 2008 model years with four-speed transmissions.
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.